GHRP-2 (GHRP2)

Growth Hormone Clinical trials

Growth Hormone Releasing Peptide-2, a potent synthetic ghrelin mimetic that strongly stimulates GH release from the pituitary gland.

Key Data

Research Status
Clinical trials
Half-Life
15-30 minutes
Administration
Subcutaneous injection
Typical Dosage
100-300 mcg

Mechanism of Action

Ghrelin receptor agonist that triggers GH release. Also slightly increases cortisol and prolactin.

Reported Benefits

All information is presented for Research Use Only (RUO). Not medical advice.

← All Peptides Dosing Calculator Community Forum Home